Kratom laws in Maryland

We list 3 Maryland rules on kratom and 7-OH products; 2 are bans.

Maryland

21+Kratom products may be sold in Maryland only to buyers 21 or older.

Md. Code, Health-Gen. § 21-2E-02(c) · draft

Exact text

§21–2E–02.
...
(c) A retailer may not distribute, sell, or expose for sale a kratom product to an individual under the age of 21 years.

BannedDo not ship to Maryland any kratom product with 7-hydroxymitragynine above 2% of the alkaloid fraction or containing synthetic mitragynine/7-OH (concentrated or synthetic 7-OH products).

Md. Code, Health-Gen. § 21-2E-02(b)(1)(iii)-(v) · draft

Exact text

§21–2E–02.
...
(b) (1) Subject to paragraph (2) of this subsection, a retailer may not prepare, distribute, sell, or expose for sale any of the following:
...
(iii) A kratom product containing a level of 7–hydroxymitragynine in the alkaloid fraction that is greater than 2% of the alkaloid composition of the product;
(iv) A kratom product containing a synthetic alkaloid, including synthetic mitragynine, synthetic 7–hydroxymitragynine, or any other synthetically derived compound of the kratom plant; or
(v) A product containing kratom that does not include on its package or label the amount of mitragynine and 7–hydroxymitragynine contained in the product.

BannedMaryland bars retailers from selling a kratom product that FDA has not recognized as a dietary ingredient or approved drug; FDA has not recognized kratom, so treat kratom sales to Maryland as prohibited.

Md. Code, Health-Gen. § 21-2E-02(a)(2)(ii) · draft

Exact text

§21–2E–02.
(2) A retailer may not prepare, distribute, sell, or expose for sale a kratom product that:
(i) Does not comply with the disclosure requirement established under paragraph (1) of this subsection; or
(ii) Has not been recognized as a dietary ingredient or approved drug by the U.S. Food and Drug Administration.

Federal

These apply in every state.

BannedMitragynine pseudoindoxyl ("MP", "pseudo") and the 7-OH derivatives MGM-15/MGM-16 are temporarily Schedule I nationwide; don't sell or ship products containing them anywhere in the US.

21 CFR 1308.11(h)(89)-(91) (DEA temporary scheduling order, 91 FR 54948, Aug. 26, 2026) · draft

Exact text

(89) Methyl (E)-2-((1'S,6'S,7'S)-6'-ethyl-4-methoxy-3-oxo- 9672
3',5',6',7',8',8a'-hexahydro-2'H-spiro[indoline-2,1'-
indolizine]-7'-yl)-3-methoxyacrylate (commonly known as
mitragynine pseudoindoxyl) including its isomers, esters,
...
(90) Methyl (E)-2-((2S,3S,7aS,12aR,12bS)-3-ethyl-7a-hydroxy-8- 9673
...
15; also known as dihydro-7-hydroxymitragynine) including its
...
(91) Methyl (E)-2-((2S,3S,7aS,12aR,12bS)-3-ethyl-9-fluoro-7a- 9674
...
(commonly known as MGM-16; also known as 9-fluoro-dihydro-7-
hydroxymitragynine; or 10-fluoro-dihydro-7-hydroxymitragynine

BannedConcentrated 7-OH products (more than 1 mg 7-OH per gram/mL, or 7-OH more than 1% of the mitragynine content) are about to become federal Schedule I nationwide (DEA order expected on or after Nov. 13, 2026), and FDA already says 7-OH can't lawfully be sold as a supplement or food; don't sell 7-OH tablets or shots.

DEA notice of intent, 91 FR 65370 (Oct. 14, 2026), proposed 21 CFR 1308.11(h)(96)-(97) · draft

Exact text

The substances [7-hydroxymitragynine] and [mitragynine
pseudoindoxyl] be controlled in schedule I [pursuant to 21 U.S.C.
811(h)] when either substance alone, or their combined amount if both
present, is:
(A) Above a specified threshold concentration, that is, greater
than 1 mg per gram (for solid powders, encapsulated material, or other
solid forms) or greater than 1 mg per milliliter (for liquid
preparations), OR
(B) The mass of mitragynine present divided by the mass of [7-
hydroxymitragynine], or [mitragynine pseudoindoxyl], or the combined
amount of [7-hydroxymitragynine] and [mitragynine pseudoindoxyl] if
both present, is less than 100.
...
The temporary scheduling order will be published in the Federal
Register on or after November 13, 2026.